Literature DB >> 33558562

Study of the fluorescence and interaction between cyclodextrins and neochlorogenic acid, in comparison with chlorogenic acid.

Silvia Navarro-Orcajada1, Adrián Matencio2, Cristina Vicente-Herrero1, Francisco García-Carmona1, José Manuel López-Nicolás3.   

Abstract

Neochlorogenic acid, a less-studied isomer of chlorogenic acid, has been seen to posses antioxidant, antifungal, anti-inflammatory and anticarcinogenic effects, which makes it an interesting candidate for incorporation in functional foods. However, its poor solubility in water and susceptibility to oxidation make such a task difficult. To overcome that, its encapsulation in cyclodextrins (CDs) is proposed. The fluorescence of neochlorogenic acid in different pH conditions was analyzed, and caffeic acid was proved to be the fluorescent moiety in the molecule. An encapsulation model whereby the ligand poses two potential complexation sites (caffeic and D-(-)-quinic moieties), showed that α-CD and HP-β-CD formed the best inclusion complexes with neochlorogenic acid, followed by M-β-CD, β-CD and γ-CD. Molecular docking with the two best CDs gave better scores for α-CD, despite HP-β-CD providing stabilization through H-bonds. The encapsulation of chlorogenic acid led to a similar CD order and scores, although constants were higher for α-CD, β-CD and M-β-CD, lower for HP-β-CD, and negligible for γ-CD. The protonation state affected these results leading to a different order of CD preference. The solubility and the susceptibility to oxidation of neochlorogenic acid improved after complexation with α-CD and HP-β-CD, while the antioxidant activity of both isomers was maintained.

Entities:  

Year:  2021        PMID: 33558562     DOI: 10.1038/s41598-021-82915-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  4 in total

1.  AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.

Authors:  Oleg Trott; Arthur J Olson
Journal:  J Comput Chem       Date:  2010-01-30       Impact factor: 3.376

2.  Sterols in human milk during lactation: bioaccessibility and estimated intakes.

Authors:  Islam J A Hamdan; Luis Manuel Sanchez-Siles; Esther Matencio; José D Bermúdez; Guadalupe Garcia-Llatas; María Jesús Lagarda
Journal:  Food Funct       Date:  2018-12-13       Impact factor: 5.396

3.  Lifespan extension in Caenorhabditis elegans by oxyresveratrol supplementation in hyper-branched cyclodextrin-based nanosponges.

Authors:  Adrián Matencio; M Alejandra Guerrero-Rubio; Fabrizio Caldera; Claudio Cecone; Francesco Trotta; Francisco García-Carmona; José Manuel López-Nicolás
Journal:  Int J Pharm       Date:  2020-09-08       Impact factor: 5.875

4.  In vitro and in vivo antitumor activity of neochlorogenic acid in human gastric carcinoma cells are complemented with ROS generation, loss of mitochondrial membrane potential and apoptosis induction.

Authors:  Wei Fang; Yuntao Ma; Juan Wang; Xiaojun Yang; Yuanhui Gu; Yiping Li
Journal:  J BUON       Date:  2019 Jan-Feb       Impact factor: 2.533

  4 in total
  3 in total

Review 1.  Advances and Classification of Cyclodextrin-Based Polymers for Food-Related Issues.

Authors:  Adrián Matencio; Alberto Rubin Pedrazzo; Alessandro Difalco; Silvia Navarro-Orcajada; Yousef Khazeai Monfared; Irene Conesa; Azam Rezayat; José Manuel López-Nicolás; Francesco Trotta
Journal:  Polymers (Basel)       Date:  2021-12-02       Impact factor: 4.329

Review 2.  Cyclodextrins as Anti-inflammatory Agents: Basis, Drugs and Perspectives.

Authors:  Silvia Lucia Appleton; Silvia Navarro-Orcajada; Francisco Juan Martínez-Navarro; Fabrizio Caldera; José Manuel López-Nicolás; Francesco Trotta; Adrián Matencio
Journal:  Biomolecules       Date:  2021-09-19

3.  Molecular encapsulation and bioactivity of gnetol, a resveratrol analogue, for use in foods.

Authors:  Silvia Navarro-Orcajada; Irene Conesa; Adrián Matencio; Francisco García-Carmona; José Manuel López-Nicolás
Journal:  J Sci Food Agric       Date:  2022-02-02       Impact factor: 4.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.